Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

January 17, 2020

The Latest on Regulations: ICH Guideline to Manage Change throughout the Commercial Lifecycle of Drugs and Combination Products – Part 2

Part 1 of this two part blog series, gave a high-level overview of the new ICH guideline <em>Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management</em>.&nbsp; In part 2 of this blog series, some of the key takeaways will be discussed in more detail.&nbsp; <em>Q12</em> is intended to help companies demonstrate increased product and process knowledge, and understand which post-approval changes will require a regulatory submission, as well as the level of reporting for each category.
Fran DeGrazio

Fran DeGrazio

VP Scientific Affairs and Technical Services


Search the Blog





  • Previous Posts
    The SmartDose Platform in use

    August 10, 2018

    Combination Products - Why Design Verification Studies Are Needed

    Daniel Bantz

    Daniel Bantz

    Technical Manager, Packaging & Performance, Lab

    SmartDose Platform

    August 08, 2018

    Performance Testing: Strategies to Qualify Combination Products

    Page McAndrew

    T. Page McAndrew, Ph.D.

    Director, Scientific Communications, SA & TS

    Mixject Admixture System

    January 30, 2018

    Co-Packaged Combination Products – System vs Component

    Doug Hostetler

    Doug Hostetler

    Principle SME, Admin. Systems, TCS

    Delivery and Safety Systems and Elastomer Components

    January 07, 2018

    Where is the Product Catalog?

    Katie Espenshade

    Katie Espenshade

    Technical Account Specialist, TCS

    Load more